Emily Griffith
Pharmacist
1026 A Ave Ne, Cedar Rapids
Iowa, 52402-5036
319-369-7105 Emily Griffith is a pharmacist in Cedar Rapids, Iowa. Patients can reach at 1026 A Ave Ne, Cedar Rapids or contact on 319-369-7105. Active license number of Emily Griffith is 24244 for Pharmacist in Iowa.
Emily Griffith is
Complete Profile:
Emily Griffith speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
| Name: | Emily Griffith |
| Specialization: | Pharmacist |
| Credentials: | PHARMD |
| Gender: | X |
| Location: | 1026 A Ave Ne, Cedar Rapids,
Iowa, 52402-5036 |
| Phone: | 319-369-7105 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Emily Griffith are as mentioned below.
| NPI Number: | 1902773260 |
| NPI Enumeration Date: | 21 Oct, 2025 |
| NPI Last Update On: | 21 Oct, 2025 |
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Griffith are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacist | 24244 | Iowa | Primary | |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1026 A Ave Ne,
Cedar Rapids, Iowa |
| Zip: | 52402-5036 |
| Phone Number: | -- |
Patients can reach Emily Griffith at
1026 A Ave Ne, Cedar Rapids, Iowa or can
call on phone at 319-369-7105.
Comments/ Reviews:
Read all the reviews posted for Emily Griffith below. You may also share your own experience with Emily Griffith. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.